| Name | Title | Contact Details |
|---|---|---|
Phil Requist |
Chief Technology Officer | Profile |
Nuo Therapeutics, Inc. (formerly Cytomedix, Inc.) is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure ulcers (bedsores).
Ossio is an orthopedic medical device company founded in Israel in 2014 with the vision to completely transform the orthopedic experience for physicians, patients, and payors. Ossio`s mission is to replace metal implants as the standard of care in the $10B+ orthopedic fixation market (screws, pins, plates) with an intelligent bone regeneration technology.
Laerdal Medical Canada is a Scarborough, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MD Buyline is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Primus Sterilizer is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.